Hemorrhage is the leading cause of death in both civilian and military trauma. The work submitted in this review is important because it advances the understanding of mechanisms that contribute to the total integrated physiological compensations for inadequate tissue oxygenation (i.e. shock) that arise from hemorrhage. Unlike an animal model, we introduce the utilization of lower body negative pressure as a noninvasive model that allows for the study of progressive reductions in central blood volume similar to those reported during actual hemorrhage in conscious humans to the onset of hemodynamic decompensation (i.e. early phase of decompensatory shock), and is repeatable in the same subject. Understanding the fundamental underlying physiology of human hemorrhage helps to test paradigms of critical care medicine, and identify and develop novel clinical practices and technologies for advanced diagnostics and therapeutics in patients with life-threatening blood loss.
Introduction
Hemorrhagic shock represents a clinical condition of inadequate tissue perfusion resulting from an acute reduction in central blood volume (central hypovolemia). 1,2 Shock is usually described by clinical markers such as severe hypotension (systolic blood pressure <90 mmHg), pronounced tachycardia (heart rate >120 bpm), metabolic acidosis (blood lactate > 2 -3 mmol/L or base deficit < À4 mmol/ L) countered by respiratory alkalosis (respiration rate >20 breaths/min with reduced EtCO 2 ), decreased pulse pressure, cold and clammy skin, and altered mental state (e.g. disorientation, confusion). 3, 4 However, there is significant individual patient variability in the compensatory response to blood loss and time course for development of shock that can render these standard metrics inconsistent and misleading to the process of diagnosis.
As such, it is the objective of this review article to present evidence obtained from various experiments conducted in our laboratory over the past 30 years on healthy humans. In an attempt to provide the reader with new insights on the physiology of blood loss in humans, mechanisms of compensation for progressive tissue hypoperfusion associated with reductions in circulating volume, and eventual onset of hemorrhagic shock due to inadequate tissue oxygenation will be reviewed.
Development of a human model of hemorrhage
The model developed for the study of human hemorrhage physiology evolved from the use of a technology known as lower body negative pressure (LBNP). A healthy human subject is placed in a pressure chamber with the torso exposed, and waist wrapped in a neoprene ''skirt'' (Figure 1(a) ). The experimental procedure for testing tolerance consists of stepwise reductions in pressure inside the chamber (Figure 1(b) ), which produces a reduction in central blood volume. The progressive hypovolemia continues until symptoms of presyncope are attained (e.g. dizziness, loss of peripheral vision, disorientation, impaired responsiveness, systolic blood pressure < 80 mmHg). When the negative pressure is released, central blood volume returns quickly to normal baseline levels (Figure 1(c) ). The completion of several hundred LBNP experiments and development of a database have revealed the classification of individuals into two general categories: two-thirds of the population display high tolerance (HT) in their ability to compensate for reduced central blood volume while the remaining one-third have a low tolerance (LT) to reduced central blood volume 5, 6 . As such, we use the criteria of those subjects who compensate beyond a À60 mmHg LBNP level as HT and those who reach presyncope at LBNP À60 mmHg as LT (Figure 1(b) ). This classification is supported by Kaplan-Meier survival curve analysis of our human LBNP database that reveals a clear separation of tolerances between individuals who failed or succeeded to complete 60 mmHg LBNP (Figure 2(a) ). The functional distinction between HT and LT individuals is important to the understanding of hemorrhage physiology in that it eloquently illustrates normal variability in compensatory human responses.
One unique and valuable feature of defining a presyncope endpoint with this model of human hemorrhage is that it has allowed us to quantify each individual's unique capacity to compensate before the onset of hemodynamic failure. This ''compensatory reserve'' can be defined and quantified as the difference between a baseline state and maximal physiological response. This definition of the reserve to compensate provides the ability to quantifiably distinguish individuals with HT (good compensators) from those with LT (poor compensators) ( Figure 2 (a)), as well as corroborate our previous observations that females demonstrate lower tolerance to central hypovolemia compared to males (Figure 2 (b)). 7
Comparison of LBNP and actual hemorrhage
Using this model, we have been able to demonstrate that hemodynamic responses to actual progressive hemorrhage can be accurately mimicked by LBNP in non-human primates and humans (Figure 1(d) ). The direct comparison with actual hemorrhage has allowed for an equivalent volume of blood loss to be accurately estimated during human LBNP. 8 As such, LBNP has repeatedly proven to simulate physiological responses to actual blood loss. 9 Cerebral perfusion associated with high and low tolerance to hemorrhage An individual's tolerance to central hypovolemia during LBNP (simulated blood loss) largely reflects a reached ''threshold'' during a progressive reduction in cerebral blood flow and oxygenation. 10 A tracing of a continuous transcranial Doppler (TCD) measurement obtained from a human subject undergoing progressive LBNP is presented in Figure 3 (a). The TCD provides a measure of mean cerebral artery velocity (MCAv) which is progressively reduced as the subject's central blood volume decreases. The experiment is abruptly terminated when the subject begins to express presyncopal symptoms, an indication of reaching a physiological threshold (MCAv < 10 cm/s) for inadequate cerebral oxygenation. Figure 3 (b) illustrates that one of the mechanisms for HT physiology is the slower rate of MCAv reduction during progressive LBNP compared to LT subjects.
Hemodynamics underlying high and low tolerance to hemorrhage
Physiological compensation is the ability to call upon the numerous mechanisms that maintain tissue and cerebral perfusion during central hypovolemia to prevent inadequate tissue oxygenation (i.e. shock). Tissue perfusion is dependent on maintaining arterial pressure (Figure 4(a) ), which is protected by mechanisms that affect cardiac output and peripheral vascular resistance (PVR). Although the longer duration to hemodynamic failure results in greater reduction in stroke volume of HT individuals ( Figure 4(d) ), cardiac output is similar to that in LT subjects (Figure 3 
Underlying autonomic mechanisms of cardiovascular compensations -the importance of sympathetic adrenergic control
In addition to differences in neuroendocrine responses ( Figure 5 (a)), Figure 5 presents data obtained from HT and LT subjects during experiments in our laboratory in which vagal and sympathetic blockade of cardiac and vascular responses were measured during tests of LBNP tolerance in an effort to assess the autonomic contribution to compensation for reduced central blood volume (e.g. hemorrhage). These experiments corroborated that greater elevations in heart rate, caused in part by reflex antagonism of the sympathetic nervous system, 11 are associated with higher tolerance to LBNP. However, while cardiac cholinergic (vagal) blockade with the use of atropine had no impact on vascular resistance ( Figure 5 and was subsequently associated with a pronounced decrease in tolerance to progressive reductions in central blood volume in both HT and LT individuals ( Figure 5(b) ). These results provided compelling evidence that sympathetically mediated tachycardia represents a critical mechanism for tolerating acute hemorrhage in addition to, and independent of, peripheral vascular constriction.
The role of sympathetically mediated oscillatory flow as a compensatory mechanism
During homeostasis and compensation, a tightly coupled, rhythmic and dynamic relationship exists between arterial pressure and sympathetic outflow. A decrease in arterial pressure quickly initiates increased sympathetic nerve activity, in part, by decreasing inhibitory afferent activity to nucleus of the solitary tract. 12 The subsequent arterial vasoconstriction results in increased vascular resistance and a compensatory elevation in arterial pressure, and the ascending arterial pressures initiate a feedback reduction in sympathetic outflow. 13 Figure 6 (a) depicts this relationship with representative diastolic blood pressure (DBP) and muscle sympathetic nerve activity (MSNA) tracings from a healthy human subject during central hypovolemia induced by 60 mmHg LBNP. The rhythmic relationship between ascending DBP and increased MSNA bursts is clearly visible (horizontal green broken lines). Similar arterial blood pressure oscillations are highly associated with an increased tolerance to central hypovolemia. [14] [15] [16] Figure 6 (b) represents two arterial pressure tracings taken from healthy human subjects during a standard LBNP protocol. The top panel represents a LT subject who experience decompensation at 30 mmHg LBNP which equated to a blood loss of only $450 mL. Note the consistent and static nature of the arterial pressure waveforms and absence of pronounced oscillations. This relationship is consistent with a lack of increased sympathetic activation in an attempt to compensate for volume loss. The second subject (bottom panel) has completed the LBNP protocol to an estimated blood loss of approximately 1200 mL, but was able to successfully compensate and did not experience presyncope symptoms or decompensation. This subject's tracing demonstrates the consistent arterial pressure oscillations that are characteristic of compensatory patterns observed in HT individuals during volume loss. As such, pronounced oscillatory patterns of circulatory pressure and flow represent a sensitive ''on-off'' sympathetically mediated feedback mechanism designed to maintain tissue oxygenation despite the compromise to blood flow under severe hypovolemic conditions. 15 In addition, there is evidence that maintaining coherence between arterial pressure and sympathetic nerve activity represents an important compensatory mechanism during hypovolemia. 16 The same relationship between oscillations in arterial blood pressure and tolerance to central hypovolemia also translates to protection of cerebral blood flow. Figure 7 (a) shows a representative tracing of MCAv from the same two subjects during the same experiment referenced in Figure 5 (Figure 7(a) , lower panel) exhibits an obvious and continuous oscillatory pattern of MCAv, again like the arterial pressure waveforms ( Figure 6(b) ). Interestingly, there is convincing evidence that these patterns of oscillation are more important than absolute velocity. In Figure 6 (b), MCAv is compared with quantified MCAv oscillations in HT and LT individuals. The HT subjects had a lower MCAv overall, but increased quantified oscillations. These data speak to the physiological importance of measuring dynamic relationships such as oscillations in pressure and flow to accurately assess the clinical status of a hemorrhaging patient rather than relying on average responses.
Underlying respiratory mechanisms of cardiovascular compensations
The respiratory system also contributes valuable mechanisms to assist with cardiovascular compensation to prevent shock during hemorrhage. Blood flow is continuously regulated by negative and positive pressures. During normal breathing, an inhalation results from the diaphragm moving down and creating a negative pressure within the thorax that encourages air to be moved into the lungs. Consequently, the reversal of this process during exhalation expels air from the lungs as the result of positive pressure. Through an anatomical paraventricular plexis, the changes in intrathoracic pressure (ITP) are transferred to the brain. Consequently, intracranial pressure (ICP) also follows the pattern of ITP (decreasing during inhalation, and increasing during expiration), assisting blood flow in the brain.
Using our human model of hemorrhage with LBNP, we have been able to investigate the relationship between respiration and hemodynamics during progressive reductions in central blood volume. We have demonstrated that we can ''optimize'' the respiratory pump by further reducing ITP with the application of increased resistance during inspiration, a process known as intrathoracic pressure regulation (IPR). 17 IPR applied during reductions in central blood volume results in increased cardiac filling and output, 18 higher arterial blood, 18 and elevated aortic and cerebral perfusion pressures (Figure 8(a) ). In addition, reductions in ITP produced by breathing against resistance are associated with greater cerebral blood flow oscillations and increased tolerance to central hypovolemia. 18 This relationship between the respiratory pump and enhanced cerebral circulation is best illustrated in Figure 8(b) and (c). Delayed expression of syncope symptoms (i.e. maintained adequate cerebral oxygenation) and increased tolerance to progressive loss of central blood volume is associated with significantly greater MCAv oscillations when ITP is decreased with application of IPR (Figure 8(b) , bottom panel) compared to no IPR (Figure 8(b) , top panel). Similar to the comparison of HT to LT individuals (Figure 7(b) ), increased tolerance in the same individual is associated with larger patterns of MCAv oscillation without differences in absolute average MCAv (Figure 8(c) ). Taken together, the data make a compelling case for the important contribution of the respiratory pump in maintaining adequate tissue perfusion during hemorrhage. 17 Onset of decompensatory shock -the ''last ditch effort''
The historical approach of using traditional vital sign measurements obtained from trauma patients suffering from hemorrhage have limited the usefulness of clinical trials designed to identify the mechanisms underlying the onset of hypovolemic shock. Our approach of using an experimentally controlled LBNP protocol as a model of progressive hemorrhage leading to presyncope in all subjects provides the unique opportunity to investigate mechanisms that contribute to the initial stage of hemodynamic decompensation in humans. In combination with computer processing techniques that provide the capability to collect and analyze electronic data in refined time sequence (milliseconds), we sought new insights into mechanisms that contribute to the transition from compensation to hemorrhage into a state of decompensatory shock.
The eventual onset of relative hypotension secondary to progressive blood loss marks the initiation of circulatory shock when perfusion pressure fails to maintain adequate tissue perfusion. 19, 20 The hemodynamic data collected by Barcroft and colleagues in 1944 during a controlled hemorrhage of 1080 cc in a human volunteer who subsequently experienced severe hypotension (Systolic Blood Pressure [SBP] < 40 mmHg) and syncope revealed a pronounced bradycardia (HR < 60 bpm) and drop in PVR. 21 However, data obtained from clinical studies have failed to consistently demonstrate responses of slowed heart rate and drop in systemic vascular resistance. Using our laboratory LBNP model of hemorrhage, we studied the time course of heart rate, vascular resistance, and sympathetic nerve activities to test the hypothesis that bradycardia and vasodilation may represent prerequisite mechanisms underlying the rapid and pronounced hypotension that results in decompensatory shock. As expected, we corroborated earlier findings that subjects with LT to central hypovolemia reached their maximal rise in HR and PVR at a similar rate but earlier than HT subjects (Figure 9 ), demonstrating their limited capacity to compensate. However, we were able to demonstrate that the reduction in systemic perfusion (arterial) pressure is marked by two mechanistic phases of hypotension. After a steady vasoconstriction mediated by elevation in vasoactive hormones and sympathetic nerve activity (Figure 4(g) and (h) ), there is a sudden reduction in mean arterial pressure from $94 mmHg to $83 mmHg at 924 s in LT subjects and $86 mmHg at 1445 s in HT subjects coincidental with a reduced peripheral vascular resistance (Figure 8, Lines 1 and 3) . This level of perfusion pressure can easily sustain adequate oxygenation to the tissue such as the brain 20 as suggested by our observation that the onset time of reduced peripheral vascular resistance occurred 47 s and 101 s before expression of syncopal symptoms by the LT and HT subjects, respectively. Since SNA remained elevated during the initial hypotension (unpublished data), this vasodilation most likely reflected the strong vasodilator effect of local metabolites (e.g. H þ , CO 2 ) generated from increased dependence on anaerobic metabolism required to meet the energy needs of hypoxic tissue. Given our observations that (1) mean arterial perfusion pressure remained adequate during vasodilation, and (2) there existed a significant time delay in both subject groups between reduced PVR and the onset of syncopal symptoms, we conclude that peripheral vasodilation is protective of oxygen delivery to hypoxic tissue but does not contribute to hemodynamic decompensation following progressive reductions in central blood volume.
The second phase of hypotension is marked by a rapid reduction in mean arterial pressure to !60 mmHg that occurred in both HT and LT subjects following a severe bradycardia (Figure 9 , Lines 2 and 4). This rapid slowing of heart rate was coincident with an equally rapid sympathetic withdrawal and minimal vagal activation as suggested by depressed cardiac baroreflex sensitivity at presycope (Figure 4(f) ). This level of perfusion pressure resulted in unsustainable cerebral tissue oxygenation, as reflected by the onset of presyncopal symptoms <10 s following a $30% drop in mean arterial pressure in both HT and LT subjects. Our findings are consistent with those of previously reported events of bradycardia observed in individuals with reduced circulating blood volume under controlled experimental conditions in humans 21, 22 and a reduced LBNP tolerance when tachycardia is blocked by propranolol during progressively reduced central blood volume. 23 Although the sudden bradycardia has been explained by the impact of low ventricular filling that initiates the Bezold-Jarish reflex, 24 our experiment extends previous findings in that we demonstrate for the first time that in addition to vagal activation, sympathetically mediated bradycardia appears to be a prerequisite physiological mechanism that contributes to hemodynamic decompensation in all humans. There is also literature supporting the notion that an ''empty heart'' might contribute to cardiac receptor stimulation resulting in afferent activation involved in a bradycardia and subsequent ''vasovagal'' syncope. 25 As such, bradycardia represents a ''last ditch effort'' to save the organism by optimizing cardiac filling time and reducing cardiac work in critically low circulating volume states when coronary blood flow is compromised. 26 
Summary
Development of a human model of hemorrhage has provided a unique opportunity to investigate the underlying physiology that defines the individual capacity to avoid the life-threatening clinical condition of inadequate tissue oxygenation known as ''shock.'' The experimental approach of progressively reducing central blood volume to the point of hemodynamic decompensation with the use of lower body negative pressure has revealed stark distinctions in the physiological compensatory responses between individuals with high compared with low tolerances to blood loss. A conceptual schematic highlighting these key interactions is presented in Figure 10 . High tolerance to hemorrhage is defined by a capacity to maintain systemic perfusion pressure and reduce the rate of cerebral hypoperfusion by: (1) protecting cardiac output with greater elevations in heart rate associated with greater cardiac vagal withdrawal and sympathetically mediated adrenergic stimulation; (2) greater increases in systemic peripheral vascular resistance associated with higher sympathetic nerve activation and levels of circulating vasopressor endocrine responses; (3) alternating blood flow between the brain and peripheral tissue with greater sympathetically mediated oscillatory ¼ 113, closed ) . The first phase of hypotension is associated with a sudden reduction in peripheral vascular resistance (vertical lines 1 and 3 for LT and HT) followed by the second phase of hypotension that is associated with a sudden reduction in heart rate (vertical lines 2 and 4 for LT and HT). Data extracted from Ryan et al. 33 (A color version of this figure is available in the online journal.) patterns of systemic pressure and flow; and (4) enhancing cardiac filling and cerebral perfusion pressure gradient by optimizing the respiratory pump. When the capacity for these compensatory responses is exhausted, an active vasodilation drops resistance to blood flow allowing for increased perfusion of peripheral tissue. When cardiac filling is no longer adequate to maintain systemic pressure and flow, a reflex-mediated pronounced bradycardia leads to the initiation of decompensatory shock.
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